Business Context and Reporting Period
Company: InMed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 6, 2021
Reporting Period Referenced: Third quarter of fiscal year 2021 ending March 31, 2021.
Key Financial Metrics
This filing is a procedural announcement regarding the timing of future financial results. It does not contain specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures for the period ending March 31, 2021.
Material Changes
No material changes to financial performance or operations are disclosed in this document. The filing solely announces the scheduled date for the release of the Q3 2021 financial results.
Guidance, Outlook, and Management Commentary
Upcoming Event: The Company announced it will report financial results for the third quarter of fiscal year 2021 on Thursday, May 13, 2021.
Legal Disclaimer: The information in this Item 7.01 and the accompanying news release (Exhibit 99.1) is furnished and not deemed "filed" under Section 18 of the Exchange Act. It shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the actual financial results released on May 13, 2021, as this 8-K only announces the date.
- Review the full text of the news release (Exhibit 99.1) referenced in the filing for any preliminary commentary.
- Confirm the company's status as an emerging growth company (indicated as yes in the filing).
- Check subsequent filings for the detailed financial statements for the quarter ended March 31, 2021.